Publisher: DelveInsight
Category: Drug Discovery

Drug Discovery market research reports by DelveInsight

(3,271 reports matching your criteria)
    • Ageing - Pipeline Insight, 2024

      Ageing - Pipeline Insight, 2024 Ageing Overview ""Ageing Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Ageing market. A detailed picture of the Ageing pipeline landscape is provided, which inclu ... Read More

    • Akt1 Inhibitor - Pipeline Insight, 2024

      Akt1 Inhibitor - Pipeline Insight, 2024 “Akt1 Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Akt1 Inhibitor development. The report provides detailed coverage of the pipeli ... Read More

    • Age-related vision dysfunction - Pipeline Insight, 2024

      Age-related vision dysfunction - Pipeline Insight, 2024 Age-related vision dysfunction Overview ""Age-related vision dysfunction Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Age-related vision ... Read More

    • Allergic Fungal Rhinosinusitis - Pipeline Insight, 2024

      Allergic Fungal Rhinosinusitis - Pipeline Insight, 2024 Allergic Fungal Rhinosinusitis Overview ""Allergic Fungal Rhinosinusitis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Allergic Fungal Rhi ... Read More

    • Adult Growth Hormone Deficiency (AGHD) - Pipeline Insight, 2024

      Adult Growth Hormone Deficiency (AGHD) - Pipeline Insight, 2024 Adult Growth Hormone Deficiency (AGHD) Overview ""Adult Growth Hormone Deficiency (AGHD) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across ... Read More

    • AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024

      AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024 AIDS Related Kaposi's Sarcoma Overview ""AIDS Related Kaposi's Sarcoma Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the AIDS Related Kaposi's ... Read More

    • Aldose Reductase Inhibitor - Pipeline Insight, 2024

      Aldose Reductase Inhibitor - Pipeline Insight, 2024 “Aldose Reductase Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Aldose Reductase Inhibitor development. The report prov ... Read More

    • Aldosterone Antagonist - Pipeline Insight, 2024

      Aldosterone Antagonist - Pipeline Insight, 2024 “Aldosterone Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Aldosterone Antagonist development. The report provides detaile ... Read More

    • Anti-Glomerular Basement Membrane (Anti-GBM) Disease - Pipeline Insight, 2024

      Anti-Glomerular Basement Membrane (Anti-GBM) Disease - Pipeline Insight, 2024 Anti-Glomerular Basement Membrane (Anti-GBM) Disease Overview ""Anti-Glomerular Basement Membrane (Anti-GBM) Disease Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical develo ... Read More

    • Arteriovenous Malformations - Pipeline Insight, 2024

      Arteriovenous Malformations - Pipeline Insight, 2024 Arteriovenous Malformations Overview ""Arteriovenous Malformations Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Arteriovenous Malformations ... Read More

    • Hypothalamic Obesity (HO) - Pipeline Insight, 2024

      Hypothalamic Obesity (HO) - Pipeline Insight, 2024 Hypothalamic Obesity (HO) Overview ""Hypothalamic Obesity (HO) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Hypothalamic Obesity (HO) market. ... Read More

    • Idiopathic Thrombocytopenic Purpura - Pipeline Insight, 2024

      Idiopathic Thrombocytopenic Purpura - Pipeline Insight, 2024 Idiopathic Thrombocytopenic Purpura Overview ""Idiopathic Thrombocytopenic Purpura Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Idio ... Read More

    • Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2024

      Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2024 “Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Kv1.3 Potassium Channel Blockers developmen ... Read More

    • Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2024

      Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2024 “Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Murine Double Minute 2 (MDM2) ... Read More

    • Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonist - Pipeline Insight, 2024

      Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonist - Pipeline Insight, 2024 “Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under ... Read More

    • Androgen receptor antagonists - Pipeline Insight, 2024

      Androgen receptor antagonists - Pipeline Insight, 2024 DelveInsight’s, “Androgen receptor antagonists - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Androgen receptor antagonists pipeline landscape. It covers the pipeline drug profiles, ... Read More

    • Tuberculosis - Pipeline Insight, 2024

      Tuberculosis - Pipeline Insight, 2024 DelveInsight’s, “Tuberculosis – Pipeline Insight, 2024,” report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in Tuberculosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

    • Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2024

      Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2024 “Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutic ... Read More

    • Alpha v Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2024

      Alpha v Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2024 “Alpha v Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha v Beta 3/5/6 Integrin Ant ... Read More

    • Alpha-2 Agonist - Pipeline Insight, 2024

      Alpha-2 Agonist - Pipeline Insight, 2024 “Alpha-2 Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-2 Agonist development. The report provides detailed coverage of the pip ... Read More

    • Anemia Associated with Chronic Kidney - Pipeline Insight, 2024

      Anemia Associated with Chronic Kidney - Pipeline Insight, 2024 Anemia Associated with Chronic Kidney Overview ""Anemia Associated with Chronic Kidney Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across th ... Read More

    • Androgen Antagonist - Pipeline Insight, 2024

      Androgen Antagonist - Pipeline Insight, 2024 “Androgen Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Androgen Antagonist development. The report provides detailed coverag ... Read More

    • ANCA Vasculitis - Pipeline Insight, 2024

      ANCA Vasculitis - Pipeline Insight, 2024 ANCA Vasculitis Overview ""ANCA Vasculitis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the ANCA Vasculitis market. A detailed picture of the ANCA Vasculiti ... Read More

    • Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2024

      Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2024 “Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects acro ... Read More

    • Anti-inflammatory - Pipeline Insight, 2024

      Anti-inflammatory - Pipeline Insight, 2024 Anti-inflammatory Overview ""Anti-inflammatory Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Anti-inflammatory market. A detailed picture of the Anti-i ... Read More

43 44 45 46 47 48 49 50

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings